Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: CareDx Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BridgeBio Pharma Inc. June 22, 202680.1%
-
Pacific Biosciences of California Inc. June 18, 202498.7%
-
CareDx Inc. June 13, 202498.5%
-
BridgeBio Pharma Inc. June 21, 202380.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 16, 2026 | CareDx Inc. | Option exercise | +7,606 | $20.56 | $156,379 |
| Jul 16, 2026 | CareDx Inc. | Option exercise | +16,048 | $14.19 | $227,721 |
| Jul 16, 2026 | CareDx Inc. | Option exercise | +5,125 | $7.96 | $40,795 |
| Jul 16, 2026 | CareDx Inc. | Open-market sale | −28,679 | $36.14 | $1,036,459 |
| Jul 16, 2026 | CareDx Inc. | Open-market sale | −100 | $36.55 | $3,655 |
| Jun 23, 2026 | BridgeBio Pharma Inc. | Open-market sale | −2,196 | $68.57 | $150,580 |
| Jun 22, 2026 | BridgeBio Pharma Inc. | Grant or award | +3,990 | — | — |
| Jun 22, 2026 | BridgeBio Pharma Inc. | Option exercise | +2,808 | $41.73 | $117,178 |
| Jun 22, 2026 | BridgeBio Pharma Inc. | Open-market sale | −2,808 | $68.00 | $190,944 |
| Jun 15, 2026 | CareDx Inc. | Open-market sale | −12,103 | $23.11 | $279,700 |
| Jun 12, 2026 | CareDx Inc. | Grant or award | +9,795 | — | — |
| Mar 10, 2026 | BridgeBio Pharma Inc. | Option exercise | +8,671 | $27.36 | $237,239 |
| Mar 10, 2026 | BridgeBio Pharma Inc. | Open-market sale | −8,671 | $72.00 | $624,312 |
| Feb 27, 2026 | BridgeBio Pharma Inc. | Option exercise | +25,484 | $48.45 | $1,234,700 |
| Feb 27, 2026 | BridgeBio Pharma Inc. | Open-market sale | −14,584 | $67.08 | $978,295 |
Questions about Hannah Valantine
What boards is Hannah Valantine on?
Hannah Valantine sits on the boards of BridgeBio Pharma Inc., CareDx Inc. and Pacific Biosciences of California Inc.
How long has Hannah Valantine served on boards?
Our records show at least 11 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.